We’re not shy about linking to information that we find useful, even if it originates with firms that compete with yours truly (or should that be “trulies?”). While we’re frequently skeptical about the value of a lot of what law firms send around under the title of “periodic alerts” (a lot of it’s just law firm propaganda), there are nuggets to be found. Today we found one that’s truly useful. If you’re interested in staying current about preemption in the context of FDA-regulated products – and you probably wouldn’t be reading this blog if you weren’t – the folks at Reed Smith have just released a really good roundup of everything that’s happened over the last six months, whether it involves drugs, devices, or vaccines. Here’s a link to the document, which is as current and comprehensive as anything we’ve seen.
Good work guys.